NEW YORK (GenomeWeb) – T2 Biosystems said today that it has received CE marking for its T2Bacteria Panel, enabling the sale and distribution of the product within the European Union countries and others accepting the mark.

The bacteria panel will be commercially available as part of the T2Sepsis Solution in Europe in the third quarter of 2017, the firm said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.